Physician

Amir A. Khan, MD

According to 2025 Medicare claims, Amir Khan, MD (NPI: 1366638074) practices infectious disease in the Champaign-Urbana, IL market, with the plurality of this provider's patient population coming from Champaign, IL. This provider's primary affiliated billing organization is CARLE HEALTH CARE INCORPORATED (NPI: 1154653947; TIN: 371140016) and primary practice location at 61801-2500. Khan is affiliated with the IRCCO (ACO ID: A2619), participating under the MSSP model.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 309 traditional Medicare patients, billed 1,269 HCPCS/CPT codes, and received $89,792 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,009 prescription claims across 172 beneficiaries totaling $2,326,547 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). 2015 DME data shows 23 claims. Open Payments data shows 6 records totaling $118. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $52,241 to $2,326,547. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	299	861	$62,790
2016	247	821	$61,075
2017	323	1,041	$81,843
2018	492	1,266	$93,059
2019	356	1,017	$80,553
2020	335	995	$79,291
2021	289	887	$70,913
2022	271	1,074	$80,426
2023	241	829	$66,130
2024	309	1,269	$89,792

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	98	226	$52,241
2016	129	794	$716,787
2017	133	937	$1,089,890
2018	187	988	$1,073,437
2019	168	1,002	$1,308,169
2020	157	947	$1,285,966
2021	142	896	$1,353,752
2022	164	1,090	$1,947,391
2023	139	976	$2,179,419
2024	172	1,009	$2,326,547

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	23	$2,015
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	138	145	$132
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	98	99	$99
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	39	50	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	51	79	$61
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	215	801	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	159	4,769	$660,683
Juluca	Dolutegravir/Rilpivirine	106	3,420	$406,150
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	67	2,010	$292,965
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	68	2,040	$268,961
Symtuza	Darunavir/Cob/Emtri/Tenof Alaf	18	840	$137,412

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$118	Shionogi Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amir A. Khan, MD?

Tedicare shows public-source Medicare data for Amir A. Khan, MD (NPI 1366638074), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amir A. Khan, MD have ACO affiliation data?

Amir A. Khan, MD is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619).

What billing organization is linked to Amir A. Khan, MD?

Amir A. Khan, MD is linked to CARLE HEALTH CARE INCORPORATED (billing NPI 1154653947) in the available physician profile data.

Does Amir A. Khan, MD have Open Payments data?

Amir A. Khan, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.